CEOs tally health-bill score
The drug industry stands to gain in a healthcare overhaul by getting tens of millions of newly insured customers, while insurance companies look like they are in for a tougher time, according to an early scorecard from executives poring over Congress's health legislation. Senate Democrats are meeting to write the bill they plan to bring to the floor, following last week's 14-9 vote in the Senate Finance Committee for a health bill that would cost $829 billion over 10 years.
- Interventional Radiology No Longer a Sub-Specialty
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- Acute Kidney Injury Gets New Focus
- Transforming Cancer Care
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Evidence-Based Practice and Nursing Research: Avoiding Confusion
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Sharp HealthCare Leaves Pioneer ACO Program
- MA an Insurance Proving Ground for Providers